Cardiometabolic Care: Assessing Patients with Diabetes Mellitus with No Overt Cardiovascular Disease in the Light of Heart Failure Development Risk

The mechanisms leading to the development of heart failure (HF) in diabetes mellitus (DM) patients are multifactorial. Assessing the risk of HF development in patients with DM is valuable not only for the identification of a high-risk subgroup, but also equally important for defining low-risk subpopulations. Nowadays, DM and HF have been recognized as sharing similar metabolic pathways. Moreover, the clinical manifestation of HF can be independent of LVEF classification. Consequently, approaching HF should be through structural, hemodynamic and functional evaluation. Thus, both imaging parameters and biomarkers are important tools for the recognition of diabetic patients at risk of HF manifestation and HF phenotypes, and arrhythmogenic risk, and eventually for prognosis, aiming to improve patients' outcomes utilizing drugs and non-pharmaceutical cardioprotective tools such as diet modification.

Automated summary

The mechanisms leading to the development of heart failure in diabetes mellitus patients are multifactorial. Assessing the risk of heart failure development in diabetic patients is valuable for identifying high-risk subgroups and defining low-risk subpopulations. Both imaging parameters and biomarkers are important tools for recognizing diabetic patients at risk of heart failure manifestation and arrhythmogenic risk, and for improving patients' outcomes utilizing drugs and non-pharmaceutical cardioprotective tools such as diet modification.